Prostate Cancer

Top Story

ADT linked to Alzheimer’s disease, dementia among older men with prostate cancer

July 18, 2019
In the Journals

Men retain sexual interest, salvage satisfaction after radical prostatectomy

July 11, 2019
Men with prostate cancer who underwent radical prostatectomy remained interested in sex despite functional losses and appeared able to salvage satisfaction, according to…
In the Journals

Hypofractionated proton therapy safe, effective among men with prostate cancer

July 10, 2019
Hypofractionated proton therapy appeared effective and associated with low rates of toxicity among men with prostate cancer, according to results of a prospective phase…
Feature

Natural Killer Cell Therapy: A Look Inside a ‘Living Drug in a Bottle’

July 9, 2019
The ability to harness the human immune system and use it to fight cancer remains a significant area of focused research and is likely to remain so until the next great…
More Headlines »
CME

2019 Texas Oncology Clinical Educational Symposium

This activity is supported by educational grants from AbbVie, Inc.; Celgene Corporation; Novartis Pharmaceuticals Corporation; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.; Takeda Oncology; and Verastem, Inc..

Clinical outcomes for advanced cancers continue to improve through the identification as well as the development of…
More »
Video
Meeting News

VIDEO: LATITUDE, STAMPEDE trials provide ‘practice-changing’ findings in prostate cancer

July 15, 2017
More »
CME CNE

Focus on Advancing Treatment for Acute Myeloid Leukemia

This activity is supported by an independent educational grant from Pfizer, Inc.

In this activity, Bruno Medieros, MD, and Farhad Ravandi-Kashini, MD, discuss recent advances in the treatment of acute…
More »